References
- Lynd L. Serotonin syndrome—the drug induced disease of the nineties. Can Pharm J 1997; 130(6)31–34
- Chan B, Graudins A, Whyte I, Dawson A, Braitberg G, Duggin G. Serotonin syndrome resulting from drug interactions. Med J Aust 1998; 169: 523–525, [PUBMED], [INFOTRIEVE]
- Carbonne J. The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 2000; 18(2)317–324
- Mills K. Serotonin syndrome—a clinical update. Crit Care Clin 1997; 13(4)763–783, [PUBMED], [INFOTRIEVE]
- Gillman P. Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust 1996; 165: 345, [PUBMED], [INFOTRIEVE]
- Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16(4)615–619, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lappin R, Auchincloss E. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331(15)1021–1022, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McDaniel W. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 2001; 35: 870–873, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Martin T. Serotonin syndrome. Ann Emerg Med 1996; 28: 520–526, [PUBMED], [INFOTRIEVE]
- Graudins A, Dowsett R P, Liddle C. The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin‐specific antidepressants. Emerg Med 2002; 14: 446–452
- Mason P, Morris V, Balcezak T. Serotonin syndrome—presentation of 2 cases and review of the literature. Medicine 2000; 79(4)201–209, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stewart R M, Campbell A, Sperk G, Baldessarini R J. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by monitoring of muscle twitches in the rat. Psychopharmacology 1979; 60: 281–289, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mylecharane E. Serotonin receptor agonists and antagonists—mechanisms of action. Aust Prescriber 1991; 14(3)46–49
- Peroutka S. 5‐Hydroxytryptamine receptor subtypes. Pharmacol Toxicol 1990; 67: 373–383, [PUBMED], [INFOTRIEVE]
- Hintze K, Wold J, Fischer L. Disposition of cyproheptadine in rats, mice, and humans and identification of a stable epoxide metabolite. Drug Metab Dispos 1975; 3(1)1–9, [PUBMED], [INFOTRIEVE]
- Product Information: Periactin (R), cyproheptadine. Merck & Co., Inc., West Point, PA 1999
- Paton D, Webster D. Clinical pharmacokinetics of H1‐receptor antagonists (The Antihistamines). Clin Pharmacokinet 1985; 10: 477–497, [PUBMED], [INFOTRIEVE]
- Iwaki M, Ogiso T, Fujii Y, Tanino T, Ito Y, Miki Y. Pharmacokinetics of cyproheptadine and its metabolites in rats. Biol Pharm Bull 1993; 16(12)1276–1281, [PUBMED], [INFOTRIEVE]
- Cooney D. Activated Charcoal in Medical Applications. Marcel Dekker, Inc., New York 1995
- The Merck Index—An Encyclopedia of Chemicals, Drugs, and Biologicals13th ed, M J O'Neil, A Smith, P E Heckelman, J R Obenchain, Jr. Merck & Co., Inc., Whitehouse Station, NJ 2001
- Martindale—The Complete Drug Reference33rd ed, S Sweetman. Pharmaceutical Press, London 2002